최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기생명과학회지 = Journal of life science, v.17 no.1 = no.81, 2007년, pp.110 - 115
문유석 (부산대학교 의학전문대학원 미생물학 및 면역학교실) , 최뢰광 (부산대학교 의학전문대학원 미생물학 및 면역학교실) , 양현 (부산대학교 의학전문대학원 미생물학 및 면역학교실)
It has been previously described that transcription factor early growth response gene product 1 (EGR-1) functions as a tumor suppressor gene. This study was conducted to demonstrate that EGR-1 induction by phytochemical apigenin and its derivative isovitexin can mediate the growth suppression of the...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
Baek, S. J., J. M. Horowitz and T. E. Eling. 2001. Molecular cloning and characterization of human non-steroidal anti-inflammatory drug-activated gene promoter. Basal transcription is mediated by Sp1 and Sp3. J. Biol. Chem. 276, 33384-33392
Baek, S. J., J. S. Kim, J. B. Nixon, R. P. DiAugustine, and T. E. Eling. 2004. Expression of NAG-1, a transforming growth factor-beta superfamily member, by troglitazone requires the early growth response gene EGR-1. J. Biol. Chem. 279, 6883-6892
Baek, S. J., J. S. Kim, S. M. Moore, S. H. Lee, J. Martinez, J. and T. E. Eling. 2005. Cyclooxygenase inhibitors induce the expression of the tumor suppressor gene EGR-1, which results in the up-regulation of NAG-1, an anti-tumorigenic protein. Mol. Pharmacol. 67, 356-364
Baek, S. J., L. C. Wilson, C. H. Lee and T. E. Eling. 2002. Dual function of nonsteroidal anti-inflammatory drugs (NSAIDs): inhibition of cyclooxygenase and induction of NSAID-activated gene. J. Pharmacol. Exp. Ther. 301, 1126-1131
Bottone, F. G., Jr., S. J. Baek, J. B. Nixon, and T. E. Eling. 2002. Dially1 disulfide (DADS) induces the anti-tumorigenic NSAID-activated gene (NAG-1) by a p53-dependent mechanism in human colorectal HCT 116 cells. J. Nutr. 132, 773-778
Castellone, M. D., H. Teramoto, B. O. Williams, K. M. Druey and J. S. Gutkind. 2005. Prostaglandin E2 promotes colon cancer cell growth through a Cs-axin-beta-catenin signaling axis. Science 310, 1504-1510
Chell, S., H. A. Patsos, D. Qualtrough, H. Z. AM, D. J. Hicks, A. Kaidi, I. R. Witherden, A. C. Williams, and C. Paraskeva. 2005. Prospects in NSAID-derived chemo-prevention of colorectal cancer. Biochem. Soc. Trans. 33, 667-671
Chintharlapalli, S., S. Papineni, S. J. Baek, S. Liu, S. and S. Safe. 2005. 1,1-Bis(3'-indoly1)-1-(p-substitutedpheny1) methanes are peroxisome proliferator-activated receptor gamma agonists but decrease HCT-116 colon cancer cell survival through receptor-independent activation of early growth response-1 and nonsteroidal anti-inflammatory drug-activated gene-1. Mol. Pharmacol. 68, 1782-1792
De Sousa, L. P., B. S. Brasil, B. M. Silva, M. H. Freitas, S. V. Nogueira, P. C. Ferreira, E. G. Kroon, and C. A. Bonjardim. 2005. Plasminogen/plasmin regulates c-fos and egr-1 expression via the MEK/ERK pathway. Biochem. Biophys. Res. Commun. 329, 237-245
Dieckgraefe, B. K. and D. M. Weems. 1999. Epithelial injury induces egr-1 and fos expression by a pathway involving protein kinase C and ERK. Am. J. Physiol. 276, G322-G330
Fenton J. I., and N. G. Hord. 2004. Flavonoids promote cell migration in nontumorigenic colon epithelial cells differing in Ape genotype: implications of matrix metalloproteinase activity. Nutr. Cancer. 48, 182-188
Fukuda, R., B. Kelly, and G. L. Semenza. 2003. Vascular endothelial growth factor gene expression in colon cancer cells exposed to prostaglandin E2 is mediated by hypoxia-inducible factor 1. Cancer Res. 63, 2330-2334
Hampton, T. 2005 NSAID studies abound in cancer research: drugs may have niche in prevention and treatment, JAMA. 293, 2579-2580
Horinaka M, T. Yoshida, T. Shiraishi, S. Nakata, M. Wakada, and T. Sakai. 2006. The dietary flavonoid apigenin sensitizes malignant tumor cells to tumor necrosis factor-related apoptosis-inducing ligand. Mol. Cancer. Ther. 5, 945-951
Husain, S. S., I. L. Szabo, and A. S. Tamawski, 2002. NSAID inhibition of GI cancer growth: clinical implications and molecular mechanisms of action. Am. J. Gastroenterol. 97, 542-553
Iczkowski, K. A. and C. G. Pantazis. 2003. Overexpression of NSAID-activated gene product in prostate cancer. Int. J. Surg. Pathol. 11, 159-166
Kune, G. A. 2000. Colorectal cancer chemoprevention: aspirin, other NSAID and COX-2 inhibitors. Aust. N. Z. J. Surg. 70, 452-455
Liang, K. W., C. T. Ting, S. C. Yin, Y. T. Chen, S. J. Lin, J. K. Liao and S. L. Hsu. 2006. Berberine suppresses MEK/ERK-dependent Egr-1 signaling pathway and inhibits vascular smooth muscle cell regrowth after in vitro mechanical injury. Biochem. Pharmacol. 71, 806-817
McVean, M., H. Xiao, K. Isobe, and J. C. Pelling. 2000. Increase in wild-type p53 stability and transactivational activity by the chemopreventive agent apigenin in keratinocytes. Carcinogenesis 21, 633-639
Moon, Y., F. G. Bottone, M. F. McEntee, T. E. Eling. 2005. Suppression of tumor cell invasion by cyclooxygenase inhibitors is mediated by thrombospondin-1 via the early growth response gene Egr-1. Mol. Cancer. Ther. 4, 1551-1558
Moon, Y., M. Lee, and H. Yang. 2006. Involvement of early growth response gene 1 in the modulation of microsomal prostaglandin E synthase1 by epigallocatechin gallate in A549 human pulmonary epithelial cells. Biochem. Pharmacol. in press
Pai, R., B. Soreghan.I. L. Szabo, M. Pavelka, D. Baatar, and A. S. Tarnawski. 2002. Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nat. Med. 8, 289-293
Shao, J., B. M. Evers, and H. Sheng. 2004. Prostaglandin E2 synergistically enhances receptor tyrosine kinase- dependent signaling system in colon cancer cells. J. Biol. Chem. 279, 14287-14293
Shao, J., C. Jung, C. Liu, and H. Sheng. 2005. Prostaglandin E2 Stimulates the beta-catenin/T cell factor-dependent transcription in colon cancer. J. Biol. Chem. 280, 26565-26572
Wang W, P. C. VanAlstyne, K. A. Irons, S. Chen, J. W. Stewart, and D. F. Birt. 2004. Individual and interactive effects of apigenin analogs on G2/M cell-cycle arrest in human colon carcinoma cell lines. Nutr. Cancer. 48, 106-114
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.